Side chain SAR of bicyclic b-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem
Bridged monobactam b-lactamase inhibitors were prepared and evaluated as potential partners for combination with imipenem to overcome class C b-lactamase mediated resistance. The (S)-azepine analog 2 was found to be effective in both in vitro and in vivo assays and was selected for preclinical devel...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 20; no. 3; pp. 918 - 921 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.02.2010
|
Online Access | Get full text |
Cover
Loading…
Summary: | Bridged monobactam b-lactamase inhibitors were prepared and evaluated as potential partners for combination with imipenem to overcome class C b-lactamase mediated resistance. The (S)-azepine analog 2 was found to be effective in both in vitro and in vivo assays and was selected for preclinical development. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Feature-2 |
ISSN: | 0960-894X |
DOI: | 10.1016/j.bmcl.2009.12.069 |